Article
Gene Therapy Mediates Therapeutic Improvement in Cardiac Hypertrophy and Survival in a Murine Model of <i>MYBPC3</i> -Associated Cardiomyopathy
2024-02-23
Abstract excerpt
<h4>Background</h4> Hypertrophic cardiomyopathy (HCM) affects an estimated 600,000 people in the U.S. and is the leading cause of sudden cardiac arrest in those under 18. Loss-of-function mutations in Myosin Binding Protein C3 , MYBPC3 , are the most common genetic cause of HCM. The majority of MYBPC3 mutations causative for HCM result in truncations. The sarcomeric pathophysiology of the majority of HCM patie...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 598e0c1b-76f0-5df4-928c-be1020b5b143
- DOI
- 10.1101/2024.02.19.581102
